2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine

C75H76BrF15N12O9 — CID 158629728

IUPAC2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine
SMILESBrCC1OCCO1.C[C@@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@H]1Oc1cc(-c2cc(F)cc(F)c2)[nH]n1.C[C@@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@H]1Oc1cc(-c2cc(F)cc(F)c2)n(CC2OCCO2)n1.C[C@@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@H]1Oc1cc(-c2cc(F)cc(F)c2)nn1CC1OCCO1
InChIInChI=1S/2C25H25F5N4O3.C21H19F5N4O.C4H7BrO2/c1-15-13-33(22-3-2-17(12-31-22)25(28,29)30)5-4-21(15)37-23-11-20(16-8-18(26)10-19(27)9-16)34(32-23)14-24-35-6-7-36-24;1-15-13-33(22-3-2-17(12-31-22)25(28,29)30)5-4-21(15)37-23-11-20(16-8-18(26)10-19(27)9-16)32-34(23)14-24-35-6-7-36-24;1-12-11-30(19-3-2-14(10-27-19)21(24,25)26)5-4-18(12)31-20-9-17(28-29-20)13-6-15(22)8-16(23)7-13;5-3-4-6-1-2-7-4/h2*2-3,8-12,15,21,24H,4-7,13-14H2,1H3;2-3,6-10,12,18H,4-5,11H2,1H3,(H,28,29);4H,1-3H2/t2*15-,21-;12-,18-;/m111./s1
InChIKeyHZAQRTFSQNUFNR-UTDJPSPVSA-N
MW1654.38 g/mol
LogP15.63
Rot. Bonds17

About 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine

2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine (PubChem CID 158629728) has the molecular formula C75H76BrF15N12O9 and a molecular weight of 1654.38 g/mol. Its IUPAC name is 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine.

Molecular Properties

Compound Name2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine
PubChem CID158629728
Molecular FormulaC75H76BrF15N12O9
Molecular Weight1654.38 g/mol
Exact Mass1652.48
IUPAC Name2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine
SMILESBrCC1OCCO1.C[C@@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@H]1Oc1cc(-c2cc(F)cc(F)c2)[nH]n1.C[C@@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@H]1Oc1cc(-c2cc(F)cc(F)c2)n(CC2OCCO2)n1.C[C@@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@H]1Oc1cc(-c2cc(F)cc(F)c2)nn1CC1OCCO1
InChIInChI=1S/2C25H25F5N4O3.C21H19F5N4O.C4H7BrO2/c1-15-13-33(22-3-2-17(12-31-22)25(28,29)30)5-4-21(15)37-23-11-20(16-8-18(26)10-19(27)9-16)34(32-23)14-24-35-6-7-36-24;1-15-13-33(22-3-2-17(12-31-22)25(28,29)30)5-4-21(15)37-23-11-20(16-8-18(26)10-19(27)9-16)32-34(23)14-24-35-6-7-36-24;1-12-11-30(19-3-2-14(10-27-19)21(24,25)26)5-4-18(12)31-20-9-17(28-29-20)13-6-15(22)8-16(23)7-13;5-3-4-6-1-2-7-4/h2*2-3,8-12,15,21,24H,4-7,13-14H2,1H3;2-3,6-10,12,18H,4-5,11H2,1H3,(H,28,29);4H,1-3H2/t2*15-,21-;12-,18-;/m111./s1
InChIKeyHZAQRTFSQNUFNR-UTDJPSPVSA-N
XLogP15.63
TPSA195.78 Ų
H-Bond Donors1
H-Bond Acceptors20
Rotatable Bonds17
Heavy Atoms112
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001654.38
LogP ≤ 515.63
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'alkyl_halide', 'substructure': 'N/A'}

Analyze 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine?
The IUPAC name of 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine (CID 158629728) is 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine.
What is the SMILES notation for 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine?
The canonical SMILES for 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine is BrCC1OCCO1.C[C@@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@H]1Oc1cc(-c2cc(F)cc(F)c2)[nH]n1.C[C@@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@H]1Oc1cc(-c2cc(F)cc(F)c2)n(CC2OCCO2)n1.C[C@@H]1CN(c2ccc(C(F)(F)F)cn2)CC[C@H]1Oc1cc(-c2cc(F)cc(F)c2)nn1CC1OCCO1.
What is the InChIKey of 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine?
The InChIKey is HZAQRTFSQNUFNR-UTDJPSPVSA-N. The full InChI is InChI=1S/2C25H25F5N4O3.C21H19F5N4O.C4H7BrO2/c1-15-13-33(22-3-2-17(12-31-22)25(28,29)30)5-4-21(15)37-23-11-20(16-8-18(26)10-19(27)9-16)34(32-23)14-24-35-6-7-36-24;1-15-13-33(22-3-2-17(12-31-22)25(28,29)30)5-4-21(15)37-23-11-20(16-8-18(26)10-19(27)9-16)32-34(23)14-24-35-6-7-36-24;1-12-11-30(19-3-2-14(10-27-19)21(24,25)26)5-4-18(12)31-20-9-17(28-29-20)13-6-15(22)8-16(23)7-13;5-3-4-6-1-2-7-4/h2*2-3,8-12,15,21,24H,4-7,13-14H2,1H3;2-3,6-10,12,18H,4-5,11H2,1H3,(H,28,29);4H,1-3H2/t2*15-,21-;12-,18-;/m111./s1.
What are the key properties of 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine?
2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine has a molecular weight of 1654.38 g/mol, XLogP of 15.63, 17 rotatable bonds, 1 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(bromomethyl)-1,3-dioxolane;2-[(3R,4R)-4-[3-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-5-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[5-(3,5-difluorophenyl)-1-(1,3-dioxolan-2-ylmethyl)pyrazol-3-yl]oxy-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine;2-[(3R,4R)-4-[[5-(3,5-difluorophenyl)-1H-pyrazol-3-yl]oxy]-3-methylpiperidin-1-yl]-5-(trifluoromethyl)pyridine is sourced from PubChem (CID 158629728), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).